Browse by Audience
Skip to content
Papers of the Week
Taselisib moderates neuropathic pain through PI3K/AKT signaling pathway in a rat model of chronic constriction injury.
Authors
You HP, Xu CJ, Zhang LH, Chen ZY, Liu WF, Wang HG, He HF, Zhang LCAbstract
Neuropathic pain is a chronic condition commonly caused by inflammation-induced disturbances or lesions of somatosensory functions in the nervous system. The aim of this study was to investigate the effects and mechanisms of Taselisib on chronic constriction injury (CCI)-induced neuropathic pain in rats.